Helix Biomedix Inc (HXBM)
23.27
0.00 (0.00%)
USD |
OTCM |
Apr 17, 16:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 3.856M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -0.13% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | -- |
Price to Book Value | -- |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -- |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 74.63% |
Profile
Helix Biomedix Inc is a specialty dermatology and consumer products skin health company with an extensive library of structurally diverse bioactive peptides and patents. The company's intellectual property portfolio offers multiple pathways for commercialization in the area ranging from Rx dermatology to aesthetic dermatology and personal care. |
URL | https://www.helixbiomedix.com |
Investor Relations URL | N/A |
HQ State/Province | Washington |
Sector | Health Care |
Industry | Biotechnology |
Equity Style | Small Cap/Growth |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Helix Biomedix Inc is a specialty dermatology and consumer products skin health company with an extensive library of structurally diverse bioactive peptides and patents. The company's intellectual property portfolio offers multiple pathways for commercialization in the area ranging from Rx dermatology to aesthetic dermatology and personal care. |
URL | https://www.helixbiomedix.com |
Investor Relations URL | N/A |
HQ State/Province | Washington |
Sector | Health Care |
Industry | Biotechnology |
Equity Style | Small Cap/Growth |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |